Ingo Vernaleken
Ingo Vernaleken
Unknown affiliation
Verified email at
Cited by
Cited by
Elevated [18F] fluorodopamine turnover in brain of patients with schizophrenia: an [18F] fluorodopa/positron emission tomography study
Y Kumakura, P Cumming, I Vernaleken, HG Buchholz, T Siessmeier, ...
Journal of Neuroscience 27 (30), 8080-8087, 2007
Therapeutic monitoring of new antipsychotic drugs
C Hiemke, A Dragicevic, G Gründer, S Hätter, J Sachse, I Vernaleken, ...
Therapeutic drug monitoring 26 (2), 156-160, 2004
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [ 18 F]Fallypride PET Study
G Gründer, C Fellows, H Janouschek, T Veselinovic, C Boy, A Bröcheler, ...
American Journal of Psychiatry 165 (8), 988-995, 2008
Positron emission tomography in CNS drug discovery and drug monitoring
M Piel, I Vernaleken, F Rösch
Journal of medicinal chemistry 57 (22), 9232-9258, 2014
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo
G Gründer, I Vernaleken, MJ Müller, E Davids, N Heydari, HG Buchholz, ...
Neuropsychopharmacology 28 (4), 787-794, 2003
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia
G Gründer, C Landvogt, I Vernaleken, HG Buchholz, J Ondracek, ...
Neuropsychopharmacology 31 (5), 1027-1035, 2006
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities
T Siessmeier, Y Zhou, HG Buchholz, C Landvogt, I Vernaleken, M Piel, ...
Journal of Nuclear Medicine 46 (6), 964-972, 2005
Modulation of [18F] fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge
I Vernaleken, Y Kumakura, P Cumming, HG Buchholz, T Siessmeier, ...
Neuroimage 30 (4), 1332-1339, 2006
Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age
I Vernaleken, C Weibrich, T Siessmeier, HG Buchholz, F Rösch, A Heinz, ...
Neuroimage 34 (3), 870-878, 2007
[18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors
G Gründer, T Siessmeier, C Lange-Asschenfeldt, I Vernaleken, ...
European journal of nuclear medicine 28, 1463-1470, 2001
‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: An exploratory [18F]‐fluoro‐L‐DOPA‐PET investigation
I Vernaleken, HG Buchholz, Y Kumakura, T Siessmeier, P Stoeter, ...
Human brain mapping 28 (10), 931-939, 2007
PET Studies of Net Blood—Brain Clearance of FDOPA to Human Brain: Age-Dependent Decline of [18F]Fluorodopamine Storage Capacity
Y Kumakura, I Vernaleken, G Gründer, P Bartenstein, A Gjedde, ...
Journal of Cerebral Blood Flow & Metabolism 25 (7), 807-819, 2005
High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia
I Vernaleken, T Siessmeier, HG Buchholz, S Härtter, C Hiemke, P Stoeter, ...
International Journal of Neuropsychopharmacology 7 (4), 421-430, 2004
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride
G Gründer, T Siessmeier, M Piel, I Vernaleken, HG Buchholz, Y Zhou, ...
Journal of Nuclear Medicine 44 (1), 109-116, 2003
Bithalamical deep brain stimulation in Tourette syndrome is associated with reduction in dopaminergic transmission
I Vernaleken, J Kuhn, D Lenartz, M Raptis, W Huff, H Janouschek, ...
Biological psychiatry 66 (10), e15-e17, 2009
The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males
T Schlüter, O Winz, K Henkel, S Prinz, L Rademacher, J Schmaljohann, ...
Journal of neuroscience 33 (43), 16889-16896, 2013
Coping with unemployment: The impact of unemployment on mental health, personality, and social interaction skills
B Pelzer, S Schaffrath, I Vernaleken
Work 48 (2), 289-295, 2014
Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging
G Gründer, C Hiemke, M Paulzen, T Veselinovic, I Vernaleken
Pharmacopsychiatry 21 (06), 236-248, 2011
Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients
W Kawohl, F Schneider, I Vernaleken, I Neuner
The world journal of biological psychiatry 10 (4-3), 827-831, 2009
Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study
Y Kumakura, I Vernaleken, HG Buchholz, P Borghammer, E Danielsen, ...
Neurobiology of aging 31 (3), 447-463, 2010
The system can't perform the operation now. Try again later.
Articles 1–20